PMCPA Case
| Case number | AUTH/2544/11/12 |
| Complainant | General practitioner |
| Company | Napp Pharmaceuticals Limited |
| Product | BuTrans (buprenorphine matrix patch) |
| Issue | Promotional emails sent to an NHS email address; question over how the address was used and whether prior permission existed |
| Channel | Email promotion via a third-party agency/resource |
| Applicable Code year | 2011 |
| Clauses considered | Clauses 9.1 and 9.9 |
| Panel decision | No breach of Clause 9.9; consequently no breach of Clause 9.1 |
| Appeal | No appeal |
| Complaint received | 6 August 2012 |
| Case completed | 15 October 2012 |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.